The Hidden Regulatory Risk In Biospecimen Sample Management

Throughout a clinical trial study, teams must ensure that they are meeting regulatory requirements. However, there is a lack of standardized specific regulatory requirements across all data points in clinical studies, making this task very difficult.

In a presentation, Chief Clinical Officer at Slope, Hope Meely, discusses clinical trial regulations and what responsibilities researchers must adhere to when meeting biospecimen requirements. Additionally, learn about what sponsors, CROs, and sites should consider when working to proactively plan for their next clinical trials involving biospecimens.